About Us
Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP’s strong research and development presence in the areas of CNS, diabetes, cardiovascular disease, and inflammation/allergy, is based on the merger in 2005 between Sumitomo Pharmaceuticals Co., Ltd., and Dainippon Pharmaceutical Co., Ltd. With global expansion plans on the horizon, this multi-billion dollar company has more than 5,000 employees worldwide. Through its research and development efforts, DSP aims to extend our experience, commitment and vision worldwide. Located in Fort Lee, NJ, Dainippon Sumitomo Pharma America, Inc. is a subsidiary of DSP. 
|
|
The origins of today's Dainippon Sumitomo Pharma (DSP) reach back over 100 years ago to deep roots in Japan. The corporation now employs more than 5000 people in research, development, manufacturing, and marketing of a broad range of drugs and chemicals. |
